Total Payments
$6,273
2024 Payments
$577.65
Companies
44
Transactions
228
Medicare Patients
6,658
Medicare Billing
$986,222
Payment Breakdown by Category
Food & Beverage$4,184 (66.7%)
Education$1,007 (16.1%)
Other$931.52 (14.8%)
Consulting$150.00 (2.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,184 | 202 | 66.7% |
| Education | $1,007 | 15 | 16.1% |
| Long term medical supply or device loan | $931.52 | 10 | 14.8% |
| Consulting Fee | $150.00 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $1,669 | 56 | $0 (2024) |
| Eisai Inc. | $502.03 | 6 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $442.09 | 28 | $0 (2023) |
| Genentech USA, Inc. | $365.02 | 16 | $0 (2023) |
| PFIZER INC. | $326.90 | 16 | $0 (2024) |
| Merck Sharp & Dohme LLC | $284.40 | 18 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $238.78 | 4 | $0 (2022) |
| Gilead Sciences, Inc. | $201.22 | 9 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $183.21 | 2 | $0 (2019) |
| Lilly USA, LLC | $161.36 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $577.65 | 20 | Eisai Inc. ($122.85) |
| 2023 | $1,188 | 43 | Novartis Pharmaceuticals Corporation ($290.83) |
| 2022 | $921.13 | 37 | Novartis Pharmaceuticals Corporation ($285.58) |
| 2021 | $1,145 | 31 | NOVARTIS PHARMACEUTICALS CORPORATION ($790.61) |
| 2020 | $425.23 | 16 | Eisai Inc. ($113.65) |
| 2019 | $781.59 | 22 | EISAI INC. ($124.08) |
| 2018 | $651.13 | 29 | E.R. Squibb & Sons, L.L.C. ($154.95) |
| 2017 | $582.92 | 30 | PFIZER INC. ($142.00) |
All Payment Transactions
228 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/23/2024 | Daiichi Sankyo Inc. | Enhertu (Drug) | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ONCOLOGY | ||||||
| 12/19/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $16.07 | General |
| Category: Oncology | ||||||
| 12/05/2024 | Novartis Pharmaceuticals Corporation | KISQALI (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: Oncology | ||||||
| 11/18/2024 | Bayer Healthcare Pharmaceuticals Inc. | Nubeqa (Drug) | Food and Beverage | In-kind items and services | $73.07 | General |
| Category: Oncology | ||||||
| 10/30/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $15.84 | General |
| Category: Oncology | ||||||
| 10/21/2024 | AstraZeneca Pharmaceuticals LP | IMFINZI (Biological) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Oncology | ||||||
| 10/17/2024 | PFIZER INC. | ELREXFIO (Drug), ADCETRIS | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: ONCOLOGY | ||||||
| 09/23/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $17.85 | General |
| Category: ONCOLOGY | ||||||
| 08/15/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.76 | General |
| Category: ONCOLOGY | ||||||
| 07/12/2024 | Novartis Pharmaceuticals Corporation | PLUVICTO (Drug) | Food and Beverage | In-kind items and services | $20.31 | General |
| Category: Oncology | ||||||
| 06/24/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: ONCOLOGY | ||||||
| 06/10/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: ONCOLOGY | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $13.29 | General |
| Category: Oncology | ||||||
| 05/02/2024 | PFIZER INC. | IBRANCE (Drug), TUKYSA | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: ONCOLOGY | ||||||
| 04/29/2024 | PFIZER INC. | BOSULIF (Drug), ELREXFIO, ADCETRIS | Food and Beverage | In-kind items and services | $21.47 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 04/25/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | Cash or cash equivalent | $122.85 | General |
| Category: Neurology | ||||||
| 04/22/2024 | Tempus AI, Inc | — | Food and Beverage | In-kind items and services | $19.28 | General |
| 04/15/2024 | SOBI, INC | DOPTELET (Drug) | Education | In-kind items and services | $85.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 03/25/2024 | ARRAY BIOPHARMA INC | LORBRENA (Drug), BRAFTOVI, MEKTOVI | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: ONCOLOGY | ||||||
| 01/08/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $13.77 | General |
| Category: ONCOLOGY | ||||||
| 12/14/2023 | Novartis Pharmaceuticals Corporation | SCEMBLIX (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: Oncology | ||||||
| 11/20/2023 | PFIZER INC. | INLYTA (Drug), XTANDI | Food and Beverage | In-kind items and services | $15.82 | General |
| Category: ONCOLOGY | ||||||
| 11/16/2023 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.43 | General |
| 11/15/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $118.44 | General |
| 11/14/2023 | Gilead Sciences, Inc. | Trodelvy (Drug) | Food and Beverage | In-kind items and services | $90.00 | General |
| Category: ONC | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,375 | 9,854 | $564,326 | $175,596 |
| 2022 | 27 | 1,721 | 20,480 | $699,178 | $213,961 |
| 2021 | 25 | 1,698 | 11,909 | $738,603 | $227,669 |
| 2020 | 29 | 1,864 | 16,138 | $1.1M | $368,996 |
Total Patients
6,658
Total Services
58,381
Medicare Billing
$986,222
Procedure Codes
100
All Medicare Procedures & Services
100 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 284 | 997 | $232,420 | $87,762 | 37.8% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2023 | 36 | 253 | $63,250 | $23,735 | 37.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 119 | 254 | $40,550 | $14,800 | 36.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 327 | 1,586 | $33,306 | $12,069 | 36.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 327 | 1,600 | $8,000 | $7,840 | 98.0% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2023 | 25 | 276 | $16,560 | $5,906 | 35.7% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2023 | 26 | 114 | $14,250 | $4,900 | 34.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 39 | $10,800 | $4,710 | 43.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $7,425 | $3,268 | 44.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 16 | 16 | $4,710 | $2,439 | 51.8% |
| 96415 | Administration of chemotherapy into vein, each additional hour | Office | 2023 | 14 | 110 | $11,000 | $2,273 | 20.7% |
| 99195 | Drawing of blood for a medical problem | Office | 2023 | 14 | 31 | $3,875 | $1,701 | 43.9% |
| 96375 | Injection of additional new drug or substance into vein | Office | 2023 | 19 | 133 | $6,650 | $1,518 | 22.8% |
| J3489 | Injection, zoledronic acid, 1 mg | Office | 2023 | 14 | 188 | $69,190 | $1,254 | 1.8% |
| J2469 | Injection, palonosetron hcl, 25 mcg | Office | 2023 | 13 | 1,161 | $27,010 | $935.63 | 3.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 21 | 2,754 | $13,770 | $260.55 | 1.9% |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | Office | 2023 | 18 | 115 | $575.00 | $93.54 | 16.3% |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | Office | 2023 | 17 | 70 | $350.00 | $70.05 | 20.0% |
| J7050 | Infusion, normal saline solution, 250 cc | Office | 2023 | 22 | 127 | $635.00 | $61.29 | 9.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 270 | 926 | $129,860 | $83,359 | 64.2% |
| 96413 | Administration of chemotherapy into vein, 1 hour or less | Office | 2022 | 43 | 277 | $69,250 | $28,378 | 41.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 188 | 343 | $34,300 | $21,161 | 61.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 358 | 1,784 | $37,464 | $13,682 | 36.5% |
| 96367 | Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | Office | 2022 | 35 | 333 | $19,980 | $7,752 | 38.8% |
| 96365 | Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | Office | 2022 | 28 | 145 | $18,125 | $7,500 | 41.4% |
About Dr. Satish Singla, M.D
Dr. Satish Singla, M.D is a Specialist healthcare provider based in Pottsville, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1730186396.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Satish Singla, M.D has received a total of $6,273 in payments from pharmaceutical and medical device companies, with $577.65 received in 2024. These payments were reported across 228 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,184).
As a Medicare-enrolled provider, Singla has provided services to 6,658 Medicare beneficiaries, totaling 58,381 services with total Medicare billing of $986,222. Data is available for 4 years (2020–2023), covering 100 distinct procedure/service records.
Ad
Practice Information
- Specialty Specialist
- Other Specialties Hematology & Oncology
- Location Pottsville, PA
- Active Since 06/28/2005
- Last Updated 10/15/2020
- Taxonomy Code 174400000X
- Entity Type Individual
- NPI Number 1730186396
Products in Payments
- KISQALI (Drug) $919.73
- OPDIVO (Biological) $398.15
- Fycompa (Drug) $336.61
- KEYTRUDA (Biological) $265.72
- PROMACTA (Drug) $190.78
- IMBRUVICA (Drug) $186.30
- SOLIRIS (Drug) $183.21
- Nubeqa (Drug) $160.36
- TYSABRI (Biological) $150.00
- Trodelvy (Drug) $125.41
- Leqembi (Drug) $122.85
- TASIGNA (Drug) $122.40
- ELIQUIS (Drug) $121.57
- VELCADE (Drug) $100.25
- Alecensa (Biological) $99.95
- ELITEK (Biological) $99.95
- ZYTIGA (Drug) $99.95
- PIQRAY (Drug) $99.27
- DOPTELET (Drug) $85.00
- SCEMBLIX (Drug) $75.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Pottsville
Mahendra Pujara, Md, MD
Specialist — Payments: $5,735
Specialist $5,735
Dr. Robert Kimmel, M.d., Facs, M.D., FACS
Specialist — Payments: $3,241
Specialist $3,241
Dr. Vincent Dauchess, D.d.s, D.D.S
Specialist — Payments: $800.00
Specialist $800.00
Ghaffar Zafar, M.d, M.D
Specialist — Payments: $333.27
Specialist $333.27
Nancy Leschik, D.o, D.O
Specialist — Payments: $67.63
Specialist $67.63
William Connolly, D.o, D.O
Specialist — Payments: $31.04
Specialist $31.04